Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine Butylbromide for Abdominal Pain in Acute Gastroenteritis
NCT04682860Phase 4Completed
- Sponsor
- Ankara City Hospital
- Start
- Sep 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hyoscine butylbromide in acute gastroenteritis, sponsored by Ankara City Hospital. Started Sep 2021; status: completed.
02
Drugs
hyoscine butylbromide
03
Conditions
acute gastroenteritis
Beyond the preview
Go deeper on NCT04682860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04682860.